Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809

NCT00437632 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Substance Dependence

Interventions

DRUG: GSK598809
DRUG: Placebo
DRUG: Caffeine

Sponsor

GlaxoSmithKline